Adaptive Biotechnologies Corp [NASDAQ: ADPT] traded at a high on 2025-06-25, posting a 12.49 gain after which it closed the day’ session at $2089999.9999999998.
The results of the trading session contributed to over 5406160 shares changing hands. Over the past one week, the price volatility of Adaptive Biotechnologies Corp stands at 5.70% while the volatility over the past one month is 2.98%.
The market cap for ADPT stock reached $1.82 billion, with 151.92 million shares outstanding and 144.91 million shares in the current float. Compared to the average trading volume of 2.09M shares, ADPT reached a trading volume of 5406160 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Adaptive Biotechnologies Corp [ADPT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ADPT shares is $11.86 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ADPT stock is a recommendation set at 1.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Craig Hallum have made an estimate for Adaptive Biotechnologies Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 18, 2025. The new note on the price target was released on March 21, 2025, representing the official price target for Adaptive Biotechnologies Corp stock. Previously, the target price had yet another raise to $15, while JP Morgan analysts kept a Overweight rating on ADPT stock.
The Price to Book ratio for the last quarter was 9.56, with the Price to Cash per share for the same quarter was set at 1.27.
How has ADPT stock performed recently?
Adaptive Biotechnologies Corp [ADPT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 18.15. With this latest performance, ADPT shares gained by 34.15% in over the last four-week period, additionally plugging by 99.67% over the last 6 months – not to mention a rise of 99.83% in the past year of trading.
Adaptive Biotechnologies Corp [ADPT]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Adaptive Biotechnologies Corp [ADPT] shares currently have an operating margin of -71.35% and a Gross Margin at 56.88%. Adaptive Biotechnologies Corp’s Net Margin is presently recorded at -74.84%.
Return on Equity for this stock declined to -25.08%, with Return on Assets sitting at -25.08%.
Earnings analysis for Adaptive Biotechnologies Corp [ADPT]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ADPT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Adaptive Biotechnologies Corp go to 30.19%.
Insider trade positions for Adaptive Biotechnologies Corp [ADPT]
There are presently around $97.70%, or 100.05% of ADPT stock, in the hands of institutional investors. The top three institutional holders of ADPT stocks are: VIKING GLOBAL INVESTORS LP with ownership of 29.99 million shares, which is approximately 20.3466%. RUBRIC CAPITAL MANAGEMENT LP, holding 14.0 million shares of the stock with an approximate value of $$50.68 million in ADPT stocks shares; and RUBRIC CAPITAL MANAGEMENT LP, currently with $$42.22 million in ADPT stock with ownership which is approximately 7.9124%.
